Lessee, Operating Lease, Liability, to be Paid, Year Three of TC BioPharm (Holdings) plc from 31 Dec 2023 to 31 Dec 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
TC BioPharm (Holdings) plc quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in GBP history and change rate from 31 Dec 2023 to 31 Dec 2024.
  • TC BioPharm (Holdings) plc Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2024 was £447,015, unchanged year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (GBP)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (GBP)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 £447,015 £0 0% 31 Dec 2024 20-F 09 May 2025 2024 FY
Q2 2024 £447,015 30 Jun 2024 6-K 25 Nov 2024 2024 Q2
Q1 2024 £447,015 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 £447,015 31 Dec 2023 10-K 01 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.